Pain Pharmacotherapy—Where are the Problems, What are the Solutions?

Share Article

New Courses at PAINWeek 2018 Examine Fentanyl Derivatives, Illicit Substances, and Abuse Deterrent Formulations in the Context of the Opioid Crisis

News Image
...ADF opioid medications should be considered, yet the patient’s insurance often will not pay for new ADF medications..

The popular Pharmacotherapy curriculum track at PAINWeek 2018 will feature new course offerings on topics of interest to the pain practitioner. In Are Bootleg Fentanyls the New Pill Mills?, offered on Saturday, September 8, senior faculty member Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHSHP, will lead a comprehensive discussion of illicit fentanyl derivatives, relative potencies, and dangers, so that participants can intelligently separate alternative facts from the real facts as they relate to opioid related deaths. Thug Drugs, to be presented on Friday, September 7, will examine similar substances on different sides of the legal boundaries, and explore what “street chemists” already know about illicit substances with similar, if not the same, mechanisms of action as legal prescription medications readily available today. Mark Garofoli, PharmD, MBA, BCGP, CPE, will lead the discussion. Also on Friday, ADFs: Gimmick or Godsend? will review the data on abuse deterrent formulations, of which more than a dozen are currently on the market. While ADFs purportedly meet the FDA demand for safer opioid medications, their expense is rarely supported by third-party insurance payers. In consequence, course presenter Michael Schatman, PhD, CPE, DASPE, observed, “The practitioner is faced with the FDA stating that ADF opioid medications should be considered, yet the patient’s insurance often will not pay for new ADF medications, and there are no corresponding generic medications available.”

PAINWeek 2018 will feature a diverse curriculum in the following course concentrations: acute pain management, advanced practice practitioners, behavioral, integrative, and interventional pain management, chronic pain syndromes, medical/legal issues, neurology, pain and chemical dependency, physical therapy, palliative care, and pharmacotherapy. There will also be full-day programs presented by the American Pain Society, the American Society of Pain Educators, the American Headache Society, and the International Pelvic Pain Society.

Practicing healthcare professionals can register to attend for the discounted price of $799 until July 31. To learn more about PAINWeek 2018, and register for the conference, click here or visit

About PAINWeek:
PAINWeek, the largest US pain conference for frontline clinicians with an interest in pain management, will convene for its 12th annual meeting on September 4-8 at the Cosmopolitan of Las Vegas. The conference presents 120+ hours of continuing medical education courses and master classes, special interest sessions, and satellite events. PAINWeek is provided by Global Education Group.

About Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Keith Dempster
+1 973.233.5569
Email >
Visit website